𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of fibroblasts and fibroblast-derived growth factors in periprosthetic angiogenesis

✍ Scribed by Miklos Tunyogi-Csapo; Tamas Koreny; Csaba Vermes; Jorge O. Galante; Joshua J. Jacobs; Tibor T. Glant


Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
350 KB
Volume
25
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The periprosthetic granulomatous soft tissue [designated iterfacial membrane (IFM) in this study] exhibits heterogeneous histopathological features, in which highly vascularized areas with dense cellularity alternate with fibrotic and pseudocapsule‐like tissue structures. Although macrophage/monocyte activation is a prominent event in the periprosthetic environment, fibroblasts also phagocytose particulate wear debris both in vivo and in vitro. Particulate wear debris and/or cytokines/growth factors alone or in combination (e.g., in conditioned media of explant cultures of IFMs) stimulated normal synovial and IFM fibroblasts to express inflammatory mediators and growth factors such as interleukin (IL)‐1β, IL‐6, IL‐8, three isoforms of vascular endothelial growth factor (VEGF), monocyte/macrophage chemoattractant protein‐1 (MCP‐1), macrophage‐colony‐stimulating factor (M‐CSF), cycloxygenases (Cox‐1 and Cox‐2), acid‐ and basic‐fibroblast growth factors (FGF‐1 and FGF‐2), leukemia inhibitory factor‐1 (LIF‐1), transforming growth factor β‐1 (TGF‐β1), receptor activator of nuclear factor‐kappa B ligand (RANKL), and osteoprotegerin (OPG). Thus, the fibroblast is capable of expressing a wide array of angiogenic and osteoclastogenic factors which are involved in the detrimental processes of the periprosthetic osteolysis. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:1378–1388, 2007


📜 SIMILAR VOLUMES


Adenovirus-mediated gene transfer of fib
✍ Roberto Pili; Joan Chang; Judith Muhlhauser; Ronald G. Crystal; Maurizio C. Capo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 284 KB

Gene transfer of angiogenic growth factors with replicationdeficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with th

Levels of vascular endothelial growth fa
✍ Nils Ole Schmidt; Manfred Westphal; Christian Hagel; Süleyman Ergün; Dimitrios S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 288 KB 👁 2 views

Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels

Expression of mouse fibroblast growth fa
✍ Tracy J. Wright; Ekaterina P. Hatch; Hakan Karabagli; Pinar Karabagli; Gary C. S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract The inner ear, which mediates hearing and equilibrium, develops from an ectodermal placode located adjacent to the developing hindbrain. Induction of the placode and its subsequent morphogenesis and differentiation into the inner ear epithelium and its sensory neurons, involves signalli

Interaction of substance P with epiderma
✍ Christian M. Kähler; Manfred Herold; Norbert Reinisch; Christian J. Wiedermann 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Substance P (SP), fibroblast growth factor (FCF), and epidermal growth factor (EGF) are mitogens for fibroblasts. EGF acts as a progression factor, whereas FGF and SP have competence factor activity. The ability of eicosanoids to regulate proliferation of fibroblasts and the increased production of

Effect of prostatic growth factor, basic
✍ Luo, Daochun; Lin, Yuqin; Liu, Xianxi; Qin, Zhijie; Zhao, Chunhua; Zhang, Yuyi; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

To study the relationship between androgen metabolism and the pathogenesis of benign prostatic hypertrophy, we purified a growth factor from benign hyperplastic tissue of human prostates and assayed the proliferative responses of human fetal prostatic fibroblasts to the purified growth factor (hPGF)